Topics

FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis

20:00 EDT 25 Mar 2020 | AAAS

(Scripps Research Institute) The US Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn's disease.

Original Article: FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis

NEXT ARTICLE

More From BioPortfolio on "FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...